Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

184 results about "Methylating Agent" patented technology

In reverse methanogenesis, methane serves as the methylating agent. [citation needed]O-Methyltransferases. A wide variety of phenols undergo O-methylation to give anisole derivatives. This process, catalyzed by enzymes such as caffeoyl-CoA O-methyltransferase, is a key reaction in the biosynthesis of lignols, percursors to lignin, a major structural component of plants.

Methods and compositions for treating symptomes of diseases related to imbalance of essential fatty acids

The invention as disclosed herein provides pharmaneutical compositions and methods for treating, ameliorating, or preventing the symptoms of fatty acids imbalance and cell membrane dysfunction. The pharmaneutical compositions of the invention contain in an effective amount a first and a second composition, the first composition comprises an effective amount of one or more phosphatidylcholine formulations and the second composition comprises an effective amount of one or more constituents comprising essential fatty acid supplements, trace minerals, phenylbutyrate, electrolytes, methylating agents, reduced glutathione, or a combination thereof, in a suitable carrier.
Owner:BODYBIO INC

New technology for recycling metribuzin methylate mother liquor

The invention provides a new technology for recycling metribuzin methylated mother liquor. The technology uses bromomethane as methylating agent to react with triazone under alkaline condition and obtain metribuzin; and methylated mother and bromine are recycled for cyclic utilization, thus achieving the aim of the reutilization of wastewater. The inorganic salt content and discharge amount of waste water in methylating working section can be effectively reduced, and the difficulty and cost of treating waste water are largely reduced. The invention has good environmental benefit, social benefit and economic benefit.
Owner:BEIJING ZIGUANG YINGLI CHEM TECH CO LTD

Preparation method of methyl p-tolyl sulfone

The invention relates to a preparation method of methyl p-tolyl sulfone, which belongs to the technical field of sulphone preparation, in particular to a preparation method of the methyl p-tolyl sulfone by taking monochloro methane as a methylating agent for synthesis. The preparation method is characterized by taking p-toluenesulfonylchloride, anhydrous sodium sulfite, sodium bicarbonate and monochloro methane as synthesizing raw materials and comprising the following operation steps: a. salifying the p-toluenesulfonylchloride; b. synthesizing the methyl p-tolyl sulfone; c. adjusting pH, reducing the temperature and discharging; d. filtering, dehydrating and drying; and e. inspecting the quality and packaging and warehousing after qualification. The invention provides a preparation methodof the methyl p-tolyl sulfone without using a deadly poisonous compound of dimethyl sulfate as a raw material, and has safe operation, environmental protection, short production period, good productquality, high yield, low production cost and strong market competitiveness. The content of the methyl p-tolyl sulfone reaches up to 99.5 percent, and the yield of the methyl p-tolyl sulfone, which iscounted by the p-toluenesulfonylchloride of the raw material, is more than or equal to 85 percent.
Owner:SHANDONG XINGHUI CHEM

Method for preparing laminine and pharmaceutically acceptable salts thereof

The invention relates to methods for preparing and using laminine and pharmaceutically acceptable salts thereof. L-lysine is used an initiative material, and the method comprises the following steps of: protecting alpha-amino groups and carboxyl with metallic salts under an alkaline condition to form a chelate complex; performing separation and purification to obtain the chelate complex with the purity of 99 to 100 percent, and performing methylation on the chelate complex on epsilon-amino groups under the action of a phase transfer catalyst with a methylating agent to generate trimethyl lysine salts; removing metallic ions with a precipitator or chelating agent to obtain crude laminine and crude pharmaceutically acceptable salts thereof; and re-crystallizing the crude laminine and the crude pharmaceutically acceptable salts thereof with a solvent to obtain the medicinal laminine and the pharmaceutically acceptable salts thereof. The methylation of the separated and purified L-lysine metallic ion chelate complex and the phase transfer catalyst are simultaneously adopted, so the method remarkably reduces the generation of monomethyl substances, dimethyl substances and other byproducts, improves the yield and achieves the product purity of over 98.5 percent (HPLC).
Owner:QINGDAO UNIV OF SCI & TECH

10-deacetylbaccatin iii and method for methoxylation of its derivative

The invention relates to 10-deacetylbaccatin III and a method for methoxylation of its derivative, which belongs to the medicine synthesis technical field. The invention is characterized in that the under the condition that 10-DAB, the 7 position and the 10 position of its derivative are hydroxy or one of them is hydroxyl, a phase transfer catalyst quaternary ammonium salt N<+>R4X<-> is added under the existence of a methylating agent, and dissolved according to a weight ratio of 1:10-100 of solute to organic solvent, and reacted with low temperature, a lower layer water phase is separated after finishing the reaction, an organic phase is washed by a saturated salt solution, and the organic phase is concentrated by concentrated acid, a petroleum ether is added for completely deposing, filtered, deposed and dried to obtain the product. The invention provides a simple and easy method for preparing the 10-DAB and a methoxy compound of the 7 position and the 10 position hydroxy of its derivative. The method for large scale intermediate preparation enables possibility of preparation of docetaxel with large dosage, and is a key step for preparing cabazitaxel.
Owner:无锡紫杉药业股份有限公司

Preparation method for producing ainothiazoly loximate by utilizing phase transfer technology

InactiveCN102070560AReduce wasteThe production process is safe and reliableOrganic chemistrySodium acetateMethylating Agent
The invention discloses a preparation method for producing ainothiazoly loximate by utilizing a phase transfer technology. The preparation method comprises the following steps: A, in an aqueous system, adding ethyl acetoacetate and sodium nitrite into a reaction kettle in proportion for reacting to obtain a nitrosation product; B, reacting the product of the ethyl acetoacetate subjected to nitrosation with a saturated aqueous solution of a methylating agent and sodium carbonate in the presence of a phase transfer catalyst by controlling the temperature, separating an aqueous layer after the reaction, and then directly carrying out chlorination; C, controlling the reaction temperature, introducing chlorine gas into the product subjected to the methylation, washing with water, and layering to obtain a chlorination reactant; D, adding thiourea, sodium acetate and phase transfer catalyst tetrabutyl ammonium chloride into the chlorination reactant, controlling the reaction temperature, and centrifugalizing the product; E, adding flake caustic soda and water into a cyclization product, regulating the pH value with hydrochloric acid, and centrifugalizing; and F, adding methyl alcohol into the centrifugalization product for refining, centrifugalizing and drying to obtain the ainothiazoly loximate. The method disclosed by the invention is easy to implement, is simple and convenient to operate, has low production cost, greatly improves the quality and yield of the product, and ensures safe and reliable production processes.
Owner:湖北楚阳科技股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products